May 27, 2017 7:05 AM ET

Healthcare Equipment and Supplies

Company Overview of Teikoku Seiyaku Co., Ltd.

Company Overview

Teikoku Seiyaku Co., Ltd. engages in the development, manufacture, and sale of medicated and medically related supplies. It offers hot sensation, and analgesic and anti-inflammatory plasters; and Lidoderm, an analgesic plaster for the treatment of post-herpetic neuralgia. The company, through its subsidiaries, also engages in the research and development of transdermal products; and production and sale of medical adhesive products and external aqueous gel preparations. In addition, the company engages in the domestic marketing of non-prescription medicines, cosmetics, and other products; manufacturing and sale of Chinese herbal medicines; and production of fruit acids, such as malic acid for...

567 Sanbonmatsu

Higashikagawa,  769-2695


Founded in 1848


81 879 25 2221


81 879 24 1555

Key Executives for Teikoku Seiyaku Co., Ltd.

Chief Executive Officer, President and Director
Age: 61
Owner and Director
Managing Director and Director
Age: 59
Senior Managing Director and Director
Senior Managing Director and Director
Compensation as of Fiscal Year 2016.

Teikoku Seiyaku Co., Ltd. Key Developments

Endo International Plc and Allergan Plc Units get Dragged to Court by US Federal Trade Commission Over Stifling Generic Competition

Endo International Plc and Allergan Plc announced that they have become the targets of a lawsuit launched by the US Federal Trade Commission (FTC), which alleges that subsidiaries of the two companies struck illegal agreements to delay the market entry of generic Opana ER and Lidoderm versions. The FTC filed its complaint on March 31, 2016, naming as guilty parties Endo Pharmaceuticals Inc, Allergan and its unit Watson Laboratories Inc, Impax Laboratories Inc, Teikoku Seiyaku Co Ltd. and Teikoku Pharma USA Inc. The two drugs at the centre of the complaint are Endo-branded products, Opana being an extended-release opioid painkiller and Lidoderm being a topical patch for relieving post-herpetic neuralgia pain. Impax and Watson were the first companies to seek approval from the US Food and Drug Administration for generic versions of these drugs. According to the FTC, Endo paid them to postpone the launch of the generic products and these so-called pay-for-delay settlements violate US antitrust laws. The complaint alleges that Endo and Impax entered into an illegal agreement in 2010, with the latter receiving more than USD 112 million (EUR 98.2 million) to hold off the launch of its Opana ER equivalent until January 2013. The amount included USD 10 million received by Impax as part of a development and co-promotion deal struck within that period. The illegal agreement with Watson over Lidoderm was signed in May 2012 and involved Endo partners Teikoku Seiyaku Co Ltd. and Teikoku Pharma USA Inc. as well. The FTC did not provide a specific figure for the payment received by Watson, saying only it amounted to hundreds of millions of dollars and the company pocketed a similar amount when it finally launched its generic version of the drug. This was the result of Endo's consent to refrain from selling an authorised Lidoderm generic version for seven and a half months, thus leaving Watson without any competition for a while.

Teikoku Seiyaku Co., Ltd. Presents at BIO-Europe 2015, Nov-02-2015

Teikoku Seiyaku Co., Ltd. Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.

Similar Private Companies By Industry

Company Name Region
3C Co., Ltd. Asia
A-Traction Inc. Asia
AdMeTech Co.,Ltd Asia
ADVANCE Co., Ltd. Asia
ALCARE Co., Ltd. Asia

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Teikoku Seiyaku Co., Ltd., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at